XML 85 R66.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments (Beginning and Ending Balance of Fixed-price Preemptive Rights and Warrants) (Details) - Level 3 [Member] - Equity Contract [Member] - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Balance at beginning of period $ 303 $ 0
Initial investment in Fixed-price Preemptive Rights and warrant 0 1,736
Exercise of Fixed-price Preemptive Rights 0 (22)
Pre-tax earnings (losses) recognized in net earnings (140) (1,411)
Balance at end of period $ 163 $ 303